29 September 2014 - US molecular diagnostic company Myriad Genetics Inc (NASDAQ:MYGN) reported Monday study findings showing that its Tumor BRACAnalysis CDx
companion diagnostic test increased by 44% the detection of cancer-causing BRCA 1/2 mutations in women with ovarian cancer.
30 May 2014 - US molecular diagnostic company Myriad Genetics Inc (NASDAQ:MYGN) said Friday it would unveil positive findings for the clinical efficacy of its BRACAnalysis CDx
and HRD tests in predicting platinum-based therapy response for breast cancer patients at the American Society of Clinical Oncology (ASCO) meeting.
- The Ministry of Health, Labor and Welfare approved US-based biotechnology company Invivoscribe's LeukoStrat CDx
FLT3 Mutation Assay as the companion diagnostic for Japanese drugmaker Daiichi Sankyo's Quizartinib for the treatment of FLT3-ITD positive relapse/ refractory acute myeloid leukemia patients in Japan, the company said.
In vitro tests of the CDX
antibody, meaning tests outside of a living organism, showed the antibody was "capable of eliminating a subset of ALL cells".
With plans to submit the assay for Pre-Market Approval in late 2019, the company's CDx
test is intended to assist clinicians in identifying patients who may benefit from treatment with specific targeted therapies.
is a specialized anatomic pathology laboratory that utilizes proprietary technology, including advanced neural-network analysis and deep artificial intelligence tools, to enhance the detection of precancerous and cancerous tissue initially in the esophagus and oral cavity.
New York, NY, July 13, 2017 --(PR.com)-- BDA Partners is pleased to announce that its client, CDx
Diagnostics, has completed a majority recapitalization by Galen Partners, a healthcare-focused growth equity investment firm.
Auto Business News-May 1, 2017--Acura US to decide on selling entry level CDX